Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2024 Earnings Call Transcript
Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2024 Earnings Call Transcript August 6, 2024Dynavax Technologies Corporation beats earnings expectations.
Dynavax Technologies Corp (DVAX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 10,900,000 | $122,407,000 | +20% | 3.65% |
| 2. | 65,119,000 | $80,529,315 | +2% | 0.01% | |
| 3. | Kynam Capital Derrick Tang | 7,082,562 | $79,537,171 | +68% | 6.13% |
| 4. | Tang Capital Management Kevin C. Tang | 2,500,000 | $28,075,000 | 2.85% | |
| 5. | Renaissance Technologies Jim Simons | 2,478,178 | $27,829,939 | +3% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 1,000,000 | Director | 8,525,000 | 2020-05-27 | Filing | |
| $3.00 | 16,666 | Director | 30,468 | 2019-08-12 | Filing | |
| $3.00 | 16,667 | Director | 16,667 | 2019-08-12 | Filing | |
| $3.00 | 16,667 | Officer | 118,484 | 2019-08-12 | Filing | |
| $4.04 | 6,000 | Officer | 12,048 | 2017-01-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.93 | 3,615 | 36,905 | 2024-05-31 | Filing | ||
| $12.78 | 13,425 | 0 | 2024-03-01 | Filing | ||
| $12.78 | 7,101 | 13,425 | 2024-03-01 | Filing | ||
| $15.00 | 1,500 | Officer | 49,925 | 2024-01-04 | Filing | |
| $14.45 | 9,000 | Officer | 3,187 | 2024-01-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,396,930 | $327,089,082 | 0% | |
| 2. | 11,364,666 | $158,878,031 | 0.39% | |
| 3. | 9,495,785 | $132,751,074 | 0% | |
| 4. | 9,275,788 | $129,675,515 | 0% | |
| 5. | 5,693,329 | $79,592,742 | 2.86% |
News See All
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript
Dynavax Technologies Corporation misses on earnings expectations. Reported EPS is $-0.06698 EPS, expectations were $-0.05.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen and welcome to the Dynavax Technologies' Fourth Quarter and Full Year 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Dynavax Technologies' Third Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.
Dynavax Technologies Corporation (NASDAQ:DVAX) Q2 2023 Earnings Call Transcript
Operator: Good day ladies and gentlemen, and welcome to Dynavax Technologies' Second Quarter 2023 Financial Results. As a reminder, this conference is being recorded.
10 Best Small Cap Pharma Stocks to Buy
In this piece, we will take a look at the ten best small cap pharma stocks to buy.
10 Best Revenue Growth Stocks to Buy
In this piece, we will take a look at the ten best revenue growth stocks to buy.
Chuck Royce Portfolio, Performance and Net Worth
In this piece, we will take a look at millionaire Chuck Royce's investment portfolio, his net worth and the overall performance of the stocks.